Transureteroureterostomy 

  • Author: Bradley Fields Schwartz, DO, FACS; Chief Editor: Edward David Kim, MD, FACS   more...
 
Updated: Jun 20, 2011
 

Background

Transureteroureterostomy (TUU) is a urinary reconstruction technique that is used to join one ureter to the other across the midline (see image below). It offers patients with distal ureteral obstruction an option to live without external urostomy appliances or internal urinary stents. TUU is also used in undiversion procedures when the surgeon wants to avoid the pelvis because of previous trauma, surgery, or radiation therapy. TUU can be combined with other procedures, such as cutaneous ureterostomy, in extreme cases.

Transureteroureterostomy. Transureteroureterostomy.

Requirements for performing a successful TUU include a salvageable ipsilateral kidney with a normal ureter proximal to the diseased portion. The accepting ureter must have unobstructed drainage and must not be affected by any disease process that would place both kidneys at risk postoperatively. Indications for TUU include trauma, pelvic malignancies, vesicoureteral reflux, exstrophy, and rare conditions such as amyloidosis, malakoplakia, and leukoplakia involving large segments of ureter. This procedure is seldom used if ureteral reimplantation using the psoas hitch or Boari flap is possible. Other options include ileal ureter, autotransplant, or nephrectomy.

The concept of TUU is to re-establish ureteral continuity by bringing the ureter across the midline and anastomosing (connecting) it to the contralateral ureter. This is generally performed in an end-to-side or side-to-side fashion. The accepting ureter must be normal because, after the TUU is performed, any disease process that affects one ureter or kidney puts the contralateral ureter and kidney at risk. TUU can also be performed in cases of a solitary kidney with a normal contralateral ureteral stump.

Next

History of the Procedure

TUU was first attempted in animals in 1906,[1] and Higgins applied it to humans in 1935.[2] Since then, TUU has been performed in children and adults for benign and malignant diseases that cause ureteral obstruction.

Previous
Next

Problem

TUU is a surgical procedure used in patients who have no other option of regaining ureteral continuity. It is used only in patients who cannot undergo reimplantation with psoas hitch or Boari flap. These patients are very challenging, and proper patient selection is important.

Previous
Next

Epidemiology

Frequency

A literature search using Medline revealed 6 articles that reported fewer than 600 cases performed worldwide from 1975 to present. This number is most likely much higher considering the fact that most procedures are not reported in scientific literature.

The largest modern series is from England, where 253 procedures were performed for both benign and malignant diseases that affected the distal ureter.[3] The authors experienced 5 complications, all of which involved the common ureter distal to the TUU. Transient leak occurred in 16 (6%) patients. This emphasizes the need to ensure a normal accepting ureter distal to the TUU anastomosis. In addition, any disease process that may risk both upper units, such as stone disease, medicorenal disease, or chronic renal insufficiency, is a contraindication to TUU.

Previous
Next

Etiology

Medical conditions that may necessitate TUU include trauma, pelvic malignancies, vesicoureteral reflux, exstrophy, and rare conditions such as amyloidosis, malakoplakia, and leukoplakia involving large segments of ureter.

Previous
Next

Presentation

Patients who require TUU present with either intrinsic or extrinsic ureteral obstruction. This may manifest as flank pain, fever, malaise, or sepsis or may be completely asymptomatic. Ultrasonography and CT scans are usually used to demonstrate unilateral or bilateral hydronephrosis.

Previous
Next

Indications

Indications for transureteroureterostomy (TUU) include trauma, pelvic malignancies, vesicoureteral reflux, exstrophy, and rare conditions such as amyloidosis, malakoplakia, and leukoplakia involving large segments of ureter. This procedure is seldom used if ureteral reimplantation using the psoas hitch or Boari flap is possible. Other options include ileal ureter, autotransplant, or nephrectomy.

Previous
Next

Relevant Anatomy

The ureters are roughly 20-30 cm long and lie completely in the retroperitoneum. They have a rich blood supply, making them relatively forgiving organs on which to operate. However, meticulous surgical technique is required in diseased ureters because they are prone to ischemia with resulting stricture formation or necrosis.

Intraoperative complications include injury to adjacent structures such as bowel or vascular structures. Care must be taken when the bowel is retracted because lacerations or mesentery injuries may occur. The aorta, inferior vena cava, and iliac vessels are in the operative field and must be identified and spared throughout the procedure. Previous surgery and/or radiation therapy increase the risk of injury to these organs.

Previous
Next

Contraindications

Contraindications to transureteroureterostomy (TUU) generally include conditions that affect both mid ureters or proximal ureters and/or kidneys. These include genitourinary tuberculosis, a long history of severe stone disease, retroperitoneal fibrosis, transitional cell carcinoma of the renal pelvis or ureter (except in cases of palliation), vesicoureteral reflux in the accepting ureter, and large luminal discrepancy in the 2 ureters. If a procedure such as a psoas hitch or Boari flap can be performed, TUU may not be the best long-term alternative for the patient. In poorly functioning kidneys (< 15%), nephrectomy may be the best option.

Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Bradley Fields Schwartz, DO, FACS  Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists

Disclosure: Nothing to disclose.

Specialty Editor Board

Michael Grasso III, MD  Director of Endourology, Lenox Hill Hospital; Professor and Vice Chairman, Department of Urology, New York Medical College

Michael Grasso III, MD is a member of the following medical societies: American Medical Association, American Urological Association, Endourological Society, Medical Society of the State of New York, National Kidney Foundation, Société Internationale d'Urologie (International Society of Urology), and Society of Laparoendoscopic Surgeons

Disclosure: Karl Storz Endoscopy Consulting fee Consulting; Boston Scientific Consulting fee Consulting; Cook Urologic Consulting fee Consulting

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Shlomo Raz, MD  Professor, Department of Surgery, Division of Urology, University of California at Los Angeles School of Medicine

Shlomo Raz, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, and California Medical Association

Disclosure: Nothing to disclose.

J Stuart Wolf Jr, MD, FACS  The David A Bloom Professor of Urology, Director, Division of Endourology and Stone Disease, Department of Urology, University of Michigan Medical School

J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology

Disclosure: Nothing to disclose.

Chief Editor

Edward David Kim, MD, FACS  Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center

Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, and Tennessee Medical Association

Disclosure: Lilly Consulting fee Advisor; Astellas Consulting fee Speaking and teaching; Watson Consulting fee Speaking and teaching; Allergan Consulting fee Speaking and teaching

References
  1. Sharpe NW. VIII. Trans-Uretero-Ureteral Anastomosis. I. Intraperitoneal. II. Retroperitoneal: (a) Anterior to Aorta and Vena Cava; (b) Posterior to Aorta and Vena Cava. Ann Surg. Nov 1906;44(5):687-707. [Medline].

  2. Higgins C. Transuretero-ureteral anastomosis. Report of a clinical case. J Urol. 1935;34:349.

  3. Noble IG, Lee KT, Mundy AR. Transuretero-ureterostomy: a review of 253 cases. Br J Urol. Jan 1997;79(1):20-3. [Medline].

  4. Iwaszko MR, Krambeck AE, Chow GK, Gettman MT. Transureteroureterostomy revisited: long-term surgical outcomes. J Urol. Mar 2010;183(3):1055-9. [Medline].

  5. Mure PY, Mollard P, Mouriquand P. Transureteroureterostomy in childhood and adolescence: long-term results in 69 cases. J Urol. Mar 2000;163(3):946-8. [Medline].

  6. Kilciler M, Bedir S, Erdemir F, et sl. Comparison of ileal conduit and transureteroureterostomy with ureterocutaneostomy urinary diversion. Urol Int. 2006;77(3):245-50. [Medline].

  7. Strup SE, Sindelar WF, Walther MM. The use of transureteroureterostomy in the management of complex ureteral problems. J Urol. May 1996;155(5):1572-4. [Medline].

  8. Dechet CB, Young MM, Segura JW. Laparoscopic transureteroureterostomy: demonstration of its feasibility in swine. J Endourol. Sep 1999;13(7):487-93. [Medline].

  9. Ehrlich RM, Skinner DG. Complications of transureteroureterostomy. J Urol. Apr 1975;113(4):467-73. [Medline].

  10. Elliott SP, McAninch JW. Ureteral injuries from external violence: the 25-year experience at San Francisco General Hospital. J Urol. Oct 2003;170(4 Pt 1):1213-6. [Medline].

  11. Hendren WH, Hensle TW. Transureteroureterostomy: experience with 75 cases. J Urol. Jun 1980;123(6):826-33. [Medline].

  12. Hodges CV, Barry JM, Fuchs EF, et al. Transureteroureterostomy: 25-year experience with 100 patients. J Urol. Jun 1980;123(6):834-8. [Medline].

  13. Maxwell KL, McDougall EM, Shalhav AL, et al. Laparoscopic ureteroureterostomy using vascular closure staples in porcine model. J Endourol. Jun 1998;12(3):265-8. [Medline].

  14. Rushton HG, Parrott TS, Woodard JR. The expanded role of transureteroureterostomy in pediatric urology. J Urol. Aug 1987;138(2):357-63. [Medline].

  15. Sandoz IL, Paull DP, MacFarlane CA. Complications with transureteroureterostomy. J Urol. Jan 1977;117(1):39-42. [Medline].

  16. Schwartz BF, Stoller ML. Endourologic management of urinary fistulae. Tech Urol. Sep 2000;6(3):193-5. [Medline].

  17. Sugarbaker PH, Gutman M, Verghese M. Transureteroureterostomy: an adjunct to the management of advanced primary and recurrent pelvic malignancy. Int J Colorectal Dis. Jan 2003;18(1):40-4. [Medline].

Previous
Next
 
Transureteroureterostomy.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.